One big dose may beat many: new palliative radiotherapy trial

NCT ID NCT04649125

Recruiting now Symptom relief Sponsor: Royal North Shore Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares a single, higher-dose palliative radiotherapy session to the usual 5-10 sessions for people with metastatic cancer. The goal is to see if one strong dose can keep symptoms away longer, up to 12 months. About 100 participants will be enrolled to measure how long the benefit lasts and how practical the single-dose approach is.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metastatic malignant neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PALLIATIVE RADIOTHERAPY

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Royal North Shore Hospital
RECRUITING

Saint Leonards, New South Wales, 2065, Australia

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact